Skip to main content

Table 2 Toxicities

From: Axitinib in combination with radiotherapy for advanced hepatocellular carcinoma: a phase I clinical trial

 

Total (n = 9)

Level I cohort (n = 3)

Level II cohort (n = 3)

Level III cohort (n = 3)

 

Grade 1–3

Grade 3

Grade 1–3

Grade 3

Grade 1–3

Grade 3

Grade 1–3

Grade 3

Leucopenia

4

0

0

0

2

0

2

0

Anemia

1

0

1

0

0

0

0

0

Thrombocytopenia

4

0

0

0

2

0

2

0

Increased ALT

5

0

2

0

1

0

2

0

Increased alkaline-P

6

0

3

0

0

0

3

0

Increased total bilirubin

6

0

2

0

1

0

3

0

Increased creatinine

2

0

1

0

1

0

0

0

Hypothyroidism

3

0

1

0

0

0

2

0

Proteinuria

6

0

2

0

1

0

3

0

Skin rash

1

0

0

0

0

0

1

0

Hand numbness

1

0

1

0

0

0

0

0

Hypertension

9

5

3

1

3

2

3

2

Nausea/vomiting

1

1

1

1

0

0

0

0

Diarrhea

3

2

1

1

1

1

1

0

Constipation

2

0

1

0

1

0

0

0